Bausch & Lomb (BLCO) FCF Payout Ratio (2024)
Bausch & Lomb's (BLCO) quarterly FCF Payout Ratio came in at 0.11 in Q3 2024.
Powered by 
Analysis
Bausch & Lomb (BLCO) FCF Payout Ratio (2024) Analysis & Trends
Bausch & Lomb (BLCO) has reported FCF Payout Ratio for 1 consecutive years, with 0.11 the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, FCF Payout Ratio changed N/A year-over-year to 0.11; the trailing twelve-month figure through Dec 2025 stood at 0.15 (up 10.61% YoY), and the FY2025 full-year result was 0.14, up 19.55% from the prior year.
- FCF Payout Ratio steadied at 0.11 in Q3 2024 per BLCO's latest filing.
- Across five years, FCF Payout Ratio topped out at 0.11 in Q3 2024 and bottomed at 0.11 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 0.55 |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 0.71 |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 0.32 |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 0.22 |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | - |